Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens Meeting Abstract


Authors: George, S.; Heinrich, M.; Chi, P.; Razak, A.; von Mehren, M.; Gordon, M.; Ganjoo, K. N.; Somaiah, N.; Trent, J. C.; Rodon Ahnert, J.; Wolf, J.; Ruiz-Soto, R.; Rosen, O.; Janku, F.
Abstract Title: Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy299.002
Language: English
ACCESSION: WOS:000459277303372
PROVIDER: wos
DOI: 10.1093/annonc/mdy299.002
Notes: Meeting Abstract: 1603O -- Appears on pages viii576-viii577 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ping Chi
    172 Chi